These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38534214)

  • 21. Prognostic value of detection of CD99
    Zakzok O; Elshanshory M; Zekri W; Elsharkawy N; Zaky I; Salama A; Kamel A; Elantably I; Said S
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29298. PubMed ID: 34403190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte infiltration into obese and fibrilized tissues is regulated by PILRα.
    Kohyama M; Matsuoka S; Shida K; Sugihara F; Aoshi T; Kishida K; Ishii KJ; Arase H
    Eur J Immunol; 2016 May; 46(5):1214-23. PubMed ID: 26840635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth.
    Vasileva E; Warren M; Triche TJ; Amatruda JF
    Elife; 2022 Mar; 11():. PubMed ID: 35285802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.
    Sand LGL; Buckle T; van Leeuwen FWB; Corver WE; Kruisselbrink AB; Jochemsen AG; Hogendoorn PCW; Szuhai K
    BMC Cancer; 2017 May; 17(1):383. PubMed ID: 28549419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
    Sohn HW; Choi EY; Kim SH; Lee IS; Chung DH; Sung UA; Hwang DH; Cho SS; Jun BH; Jang JJ; Chi JG; Park SH
    Am J Pathol; 1998 Dec; 153(6):1937-45. PubMed ID: 9846983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
    Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
    Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
    Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
    Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment.
    Denton NL; Chen CY; Hutzen B; Currier MA; Scott T; Nartker B; Leddon JL; Wang PY; Srinivas R; Cassady KA; Goins WF; Cripe TP
    Mol Ther Oncolytics; 2018 Dec; 11():62-74. PubMed ID: 30505937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
    Çelik H; Sciandra M; Flashner B; Gelmez E; Kayraklıoğlu N; Allegakoen DV; Petro JR; Conn EJ; Hour S; Han J; Oktay L; Tiwari PB; Hayran M; Harris BT; Manara MC; Toretsky JA; Scotlandi K; Üren A
    Oncogene; 2018 Apr; 37(16):2181-2196. PubMed ID: 29382926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
    Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
    Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma.
    Olsen SH; Thomas DG; Lucas DR
    Mod Pathol; 2006 May; 19(5):659-68. PubMed ID: 16528378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD99 ligation upregulates HSP70 on acute lymphoblastic leukemia cells and concomitantly increases NK cytotoxicity.
    Husak Z; Dworzak MN
    Cell Death Dis; 2012 Nov; 3(11):e425. PubMed ID: 23152061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.
    Martinelli M; Parra A; Scapoli L; De Sanctis P; Chiadini V; Hattinger C; Picci P; Zucchini C; Scotlandi K
    Oncotarget; 2016 Nov; 7(47):77958-77967. PubMed ID: 27792997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
    Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.
    Henrich IC; Jain K; Young R; Quick L; Lindsay JM; Park DH; Oliveira AM; Blobel GA; Chou MM
    Cancer Res; 2021 Apr; 81(8):2171-2183. PubMed ID: 33558334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell Adhesion Molecule CD99 in Cancer Immunotherapy.
    Yu F; Liu G; Zhang H; Wang X; Wu Z; Xu Q; Wu Y; Chen D
    Curr Mol Med; 2023; 23(10):1028-1036. PubMed ID: 36214301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma.
    Jain K; Henrich IC; Quick L; Young R; Mondal S; Oliveira AM; Blobel GA; Chou MM
    Cancer Res Commun; 2023 Aug; 3(8):1615-1627. PubMed ID: 37615015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
    Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
    Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
    Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
    Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
    de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
    Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.